Catheter-base medical device for structural heart disease
Business Model:
Revenue: $0
Employees: 11-50
Address:
City: Reston
State: Virginia
Zip:
Country: United States
TAU is developing state-of-the-art minimally invasive catheter-based surgical methodologies for treating structural heart diseases like Tricuspid Valve Regurgitation (TR), Mitral Valve Regurgitation (MR), Hypertrophic Obstructive Cardiomyopathy (HOCM), and Heart arrhythmia.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2020 | Series B | 3 | $22M |
Smilegate Investment STIC Ventures Stonebridge Capital Smilegate Investment STIC Ventures Stonebridge Capital |
3/2017 | Series A | 1 | $4.5M |
Stonebridge Capital Stonebridge Capital |
2/2019 | Venture Round | 1 | $2.7M |
Stonebridge Capital Stonebridge Capital |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|